Skip to content

Arts and culture on prescription

Arts and culture on prescription. The impact of cultural prescription on the health of the elderly population living in the Lugano municipality – A pilot project.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11875351
Enrollment
100
Registered
2025-09-19
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly health Other

Interventions

A link worker from the Città di Lugano will contact participants to provide detailed information about the available cultural offerings and the research procedure. The link worker will work closely wi

Sponsors

IBSA Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 65 or older 2. Resident in the Lugano municipality 3. Having access to a GP 4. Diagnosed > six months with one or more of the following pathological conditions: Obesity (BMI =30); Obstructive sleep apnea syndrome; Type 2 Diabetes Mellitus; Chronic Obstructive Pulmonary Disease (COPD) (GOLD 2 or higher); Uncontrolled hypertension; Uncontrolled gouty arthritis; Metabolic dysfunction and alcohol-related liver disease (MetALD)

Exclusion criteria

Exclusion criteria: 1. Individuals who are still in employment (as the study focuses on retirees). Those who undertake occasional freelance work or small consultancies (e.g., fewer than 8 hours per week) may still be eligible, provided their professional activities do not interfere with participation in the study 2. Individuals diagnosed with moderate to severe dementia or cognitive impairment that affects their ability to provide informed consent 3. Individuals with significant mobility restrictions that would prevent engagement in artistic and cultural activities (unless safe accommodations can be arranged)

Design outcomes

Primary

MeasureTime frame
Uptake and feasibility of recruitment and research procedures measured using attendance records (reported by facilitators and self-report), GP screening logs, and rates of completion of follow-up assessments at baseline, 6 months, and 12 months

Secondary

MeasureTime frame
1. Health orientation measured using the Health Orientation Scale (HOS) at baseline, 6 months, and 12 months 2. Mental health and well-being measured using the following validated questionnaires at baseline, 6 months, and 12 months: 2.1. Generalized Anxiety Disorder Assessment-7 (GAD-7) 2.2. Patient Health Questionnaire-9 (PHQ-9) 2.3. Warwick-Edinburgh Mental Wellbeing Scale 2.4. Self-Compassion Scale Short Form (SCS-SF) 2.5. WHO-5 Well-Being Index 2.6. EQ-5D 2.7. Three-item UCLA Loneliness Scale 2.8. Medical Outcomes Study Social Support Survey 2.9. Bernese Sleep Health Questionnaire (BSHQ) 3. Physiological measures measured using clinical examination, wearable device (Garmin vívoactive® 5), and lab tests at baseline, 6 months, and 12 months: 3.1. Clinical: blood pressure, anthropometry, bioimpedance, Mini-Mental State Exam, and Clock Test 3.2. Wearable: heart rate variability (HRV), sleep quality, physical activity, stress (via smartwatch) 3.3. Laboratory: HbA1c, GGT, uric acid, ALAT, creatinine (blood); sodium, potassium, albumin, creatinine (urine) 4. Consultations and hospitalizations/emergency department accesses measured using a structured GP questionnaire (review of medical records) at 12 months

Countries

Switzerland

Contacts

Public ContactLuca Gabutti
luca.gabutti@eoc.ch+41 91 811 84 65

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026